Clinical Trial Update: Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Nephropathy [NA]

View source ↗

Summary

A completed clinical trial evaluated neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for detecting contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Medical University of Graz | Conditions: Contrast Media Induced Nephropathy (CIN) | NA | Status: COMPLETED